GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genus GNS.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

2,066.00p

-2.82%

Close of 20 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Genus — daily GNS

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Genus on TradingView ↗
Market value
£1.38bn
Last close × shares
Volume
193.1k
Shares, 20 Nov 2026
Price to earnings
559.5
Dividend yield
0.01%

About Genus

Its shares trade on LSE under the ticker GNS.L. It has been listed since 6 July 2000. In the fiscal year to 30 June 2026, it reported revenue of £658.1m and net income of £285.3m. At that date it held total assets of £1.02bn and shareholders' equity of £766.7m.

Genus Plc engages in the provision of genetic livestock services to produce meat and milk. The company is headquartered in Basingstoke, Hampshire. The company went IPO on 2000-07-06. The firm's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment is engaged in bovine sales business, excluding Asia, and serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment is engaged in porcine and bovine business in Asia, and serves porcine, dairy and beef customers in Asian markets. In the porcine market, it sells boars and sows. In the dairy and beef markets, its primary product is bull semen. The firm offers embryos through its subsidiary, In Vitro Brasil S.A. Its porcine business has a network of over 600 breeding herds in approximately 40 countries.

Figures and description from our data supplier, not checked against the company's own report.

More about Genus →

Latest on Genus

Our reporting

Next results

25 Feb 2027

Due on 25 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Genus's ticker?

Genus trades as GNS.L on LSE, under ISIN GB0002074580.

What was Genus's last closing price?

2,066.00p on 20 Nov 2026. The figure is in GBp and is never converted.

When does Genus next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.